CVS Health Corp (NYSE:CVS) shares, rose in value, with the stock price down by -0.19% to the previous day’s close as strong demand from buyers drove the stock to $66.53.
Actively observing the price movement in the recent trading, the stock is buoying the session at $66.66, falling within a range of $65.61 and $66.88. The value of beta (5-year monthly) is 0.561 whereas the PE ratio is 15.89 over 12-month period. Referring to stock’s 52-week performance, its high was $72.51, and the low was $43.56. On the whole, CVS has fluctuated by 4.18% over the past month.
With the market capitalization of CVS Health Corp currently standing at about $84.16 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-01. The company’s Forward Dividend Ratio is 2.66, with its dividend yield at 4.00%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 387.12B, with a low estimate of 91.19B and a high estimate of 98.8B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 94.75B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVS’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.15, with the price of CVS currently trading nearly -1.03% and 1.97% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 50.40, while the 7-day volatility ratio is showing 2.27% which for the 30-day chart, stands at 2.08%. Furthermore, CVS Health Corp (CVS)’s beta value is 0.60.
A comparison of CVS Health Corp (CVS) with its peers suggests the former has fared considerably weaker in the market. CVS showed an intraday change of -0.19% in today’s session so far, and over the past year, it grew by 48.21%%.
Data on historical trading for CVS Health Corp (NYSE:CVS) indicates that the trading volumes over the past 10 days have averaged 6.5 and over the past 3 months, they’ve averaged 9.04 million. According to company’s latest data on outstanding shares, there are 1.27 billion shares outstanding.
Nearly 0.15% of CVS Health Corp’s shares belong to company insiders and institutional investors own 86.57% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 18.71 million shares as on 2025-06-13, resulting in a short ratio of 2.22. According to the data, the short interest in CVS Health Corp (CVS) stood at 150.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 15.9 million. The stock has risen by 16.95% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVS stock heading into the next quarter.
